Investment management firm Cohen & Steers (NYSE: CNS) will be announcing earnings results this Thursday afternoon. Here’s what investors should know.

Cohen & Steers beat analysts’ revenue expectations by 2.1% last quarter, reporting revenues of $141.7 million, up 6.4% year on year. It was a strong quarter for the company, with a decent beat of analysts’ revenue estimates and a beat of analysts’ EPS estimates.

Is Cohen & Steers a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, analysts are expecting Cohen & Steers’s revenue to grow 2.4% year on year to $143.2 million, slowing from the 17.3% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.81 per share.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Cohen & Steers has missed Wall Street’s revenue estimates four times over the last two years.

Looking at Cohen & Steers’s peers in the capital markets segment, some have already reported their Q4 results, giving us a hint as to what we can expect. State Street delivered year-on-year revenue growth of 7.5%, beating analysts’ expectations by 1.5%, and BNY reported revenues up 6.8%, topping estimates by 0.7%. State Street traded down 8.1% following the results while BNY was also down 49.4%.

Read our full analysis of State Street’s results here and BNY’s results here.

Investors in the capital markets segment have had steady hands going into earnings, with share prices flat over the last month. Cohen & Steers is up 8.5% during the same time and is heading into earnings with an average analyst price target of $72.33 (compared to the current share price of $68.70).

P.S. STOP buying the AI stocks everyone's talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.